Chronic heart failure in the United States: a manifestation of coronary artery disease

M Gheorghiade, RO Bonow - Circulation, 1998 - Am Heart Assoc
decrease the need for cardiac transplantation. 53 These paradoxical responses have been
attributed to the fact that many inotropic and vasodilating agents enhance cardiac …

[HTML][HTML] Coronary risk factors and plaque morphology in men with coronary disease who died suddenly

AP Burke, A Farb, GT Malcom, Y Liang… - … England Journal of …, 1997 - Mass Medical Soc
Background Cigarette smoking and abnormal serum cholesterol concentrations are risk
factors for acute coronary syndromes, but the underlying mechanisms are poorly …

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association

L Mosca, JAE Manson, SE Sutherland, RD Langer… - Circulation, 1997 - Am Heart Assoc
Despite an overall reduction in the death rate due to cardiovascular disease (CVD) in the
United States over the last several decades, the rate of decline is less for women than men …

Prevention and management of chronic heart failure in management of asymptomatic patients

M Frigerio, F Oliva, FM Turazza, RO Bonow - The American journal of …, 2003 - Elsevier
Symptomatic heart failure is preceded by a somewhat prolonged asymptomatic stage in
many patients. The number of patients with asymptomatic heart dysfunction is about 4-fold …

[HTML][HTML] Estudio de prevención secundaria de la cardiopatía isquémica en la atención primaria (PRESENCIAP)

E Avellana, G PRESENCIAP - Atención Primaria, 2001 - Elsevier
Objetivo Conocer el grado de registro y control de los factores de riesgo cardiovascular
entre los pacientes con cardiopatía isquémica crónica (CIPSAP 2-Definida) y el uso de …

Prescribing of β-blockers after myocardial infarction: A preliminary study of physician motivations and barriers

J Kavookjian, S Mamidi - Clinical Therapeutics, 2008 - Elsevier
Background: Clinical practice guidelines (CPGs) recommend β-blocker medications in the
management of post-myocardial infarction (MI) patients to prevent subsequent MI; evidence …

General pharmacologic treatment of acute myocardial infarction

AW Shannon, RA Harrigan - Emergency medicine clinics of North America, 2001 - Elsevier
Pharmacotherapy for acute myocardial infarction (AMI) encompasses many therapeutic
areas, including treatment of the event itself and its possible complications …

Effect of a novel NSAID derivative with antioxidant moiety on oxidative damage caused by liver and cerebral ischaemia‐reperfusion in rats

AP Kourounakis, K Tsiakitzis… - Journal of pharmacy …, 2002 - Wiley Online Library
Tissue ischaemia‐reperfusion evokes toxic and harmful biochemical processes such as
oxidative stress and inflammation. The aim of this study is to investigate the indices of tissue …

Antiischemic therapy in patients with coronary heart disease living in long‐term care

KL Lapane, MM Barbour, A Van Haaren… - … : The Journal of …, 1999 - Wiley Online Library
We evaluated antiischemic therapy in elderly nursing home residents with a diagnosis of
coronary heart disease (CHD) using a population‐based data base with over 300,000 …

drug therapy of sustained ventricular tachyarrhythmias: Is there still a role?

LB Mitchell - Cardiology Clinics, 2000 - Elsevier
A patient who has experienced sustained ventricular tachycardia (VT) or ventricular
fibrillation (VF) in the absence of a reversible or transient cause is at high risk of recurrent …